Human tumor xenograft models for preclinical assessment of anticancer drug development.
about
Identification of Biomarkers for Breast Cancer Using Databases.Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates.X-shaped DNA potentiates therapeutic efficacy in colitis-associated colon cancer through dual activation of TLR9 and inflammasomesMannan-modified adenovirus targeting TERT and VEGFR-2: A universal tumour vaccine.11-Substituted Benzo[c]phenanthridines: New Structures and Insight into Their Mode of Antiproliferative Action.Patterns of Vasculature in Mouse Models of Lung Cancer Are Dependent on Location.Optical imaging of gastric cancer with near-infrared heptamethine carbocyanine fluorescence dyes.An improved intrafemoral injection with minimized leakage as an orthotopic mouse model of osteosarcomaDetecting Tumor Metastases: The Road to Therapy Starts Here.Potential use of nanocarriers with pentacyclic triterpenes in cancer treatments.Current mathematical models for cancer drug discovery.Characterization of an Orthotopic Colorectal Cancer Mouse Model and Its Feasibility for Accurate Quantification in Positron Emission Tomography.Human MAP Tau Based Targeted Cytolytic Fusion Proteins.Testing PARP Inhibitors Using a Murine Xenograft Model.Quantitative translational modeling to facilitate preclinical to clinical efficacy & toxicity translation in oncology.Patient-Derived Xenograft Models for Endometrial Cancer Research
P2860
Q30239810-DD916153-88DA-4423-8248-1E6CE61DD09FQ33808096-555ABA61-202E-4CBC-BCA7-298D1404FABDQ35604586-E512FD9F-AD54-4FFB-9828-CD1BC7BF7C78Q35753931-BBABE190-A3D9-44C3-B112-D2E1D4509F7EQ36108617-BCE1255B-D1F5-4979-AFB4-9F237FA2D5E0Q36154645-5DBF8995-BFD6-4422-9BAF-15F3EF989AA2Q37636793-BE61BF2C-BE5D-45AF-8167-92872B1E6ADCQ38856757-724A4FE4-EA52-43EF-B711-B76A7E31BAE0Q38950545-99A496EB-3D8A-4355-B941-67F6246BC395Q38997510-2B50EBC8-5E92-4C32-B017-AF3696168F0AQ39359967-26952F49-B89C-460D-A632-A6868E49E25EQ48242134-2BDE9327-A10A-4FB7-AC6F-67AA5488267FQ50921086-5A82DAF9-F2E3-485A-AC10-D1DF1CFA0FE2Q53170125-8614FB3B-8240-4EA7-A51E-39C98E737344Q55329667-8E22EFC2-C3E2-425A-9706-C2FBD15CD03EQ58768056-23A117E5-C645-4CA3-904E-55152FB3C290
P2860
Human tumor xenograft models for preclinical assessment of anticancer drug development.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Human tumor xenograft models for preclinical assessment of anticancer drug development.
@ast
Human tumor xenograft models for preclinical assessment of anticancer drug development.
@en
Human tumor xenograft models for preclinical assessment of anticancer drug development.
@nl
type
label
Human tumor xenograft models for preclinical assessment of anticancer drug development.
@ast
Human tumor xenograft models for preclinical assessment of anticancer drug development.
@en
Human tumor xenograft models for preclinical assessment of anticancer drug development.
@nl
prefLabel
Human tumor xenograft models for preclinical assessment of anticancer drug development.
@ast
Human tumor xenograft models for preclinical assessment of anticancer drug development.
@en
Human tumor xenograft models for preclinical assessment of anticancer drug development.
@nl
P2860
P356
P1476
Human tumor xenograft models for preclinical assessment of anticancer drug development.
@en
P2093
Joohee Jung
P2860
P356
10.5487/TR.2014.30.1.001
P577
2014-03-01T00:00:00Z